NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/05/2026
Back to search
Official data from USPTO
IMMUNOVX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
05/05/2026
Trademark type
Word
Nice classes
42
Filing date
07/18/2023
Registration date
05/05/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2026
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/23/2023
First use in commerce
07/23/2023
Drawing code
4
Owner type
01
Owner location
Bethlehem, PA, US
Examiner
CHHINA, KARANENDRA S
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Banerjee, Dalfoni, G.
Banerjee, Dalfoni, G.
Representatives
Sean P. McConnell Troutman Pepper Locke LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Clinical research in the field of pharmaceuticalbiologicbiotechnologyvaccineinfectious disease treatmentadjuvant research and development; Research and development and consultation related thereto in the field of pharmaceuticalbiologicbiotechnologyvaccineinfectious disease treatmentadjuvant research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research; Scientific research consulting; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Consulting services for others in the field of designplanningimplementation project management of pharmaceuticalbiologicbiotechnologyvaccineinfectious disease treatmentadjuvant research and development; Medical and scientific research in the field of pharmaceuticalbiologicbiotechnologyvaccineinfectious disease treatmentadjuvant research and development; Medical and scientific researchconducting clinical trials for others; Pharmaceutical research and development; Product research and development; Providing information about medical and scientific research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticalbiologicbiotechnologyvaccineinfectious disease treatmentadjuvant research and development
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/13/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/13/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/02/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/28/2026
IUAF
USE AMENDMENT FILED
08/25/2025
EISU
TEAS STATEMENT OF USE RECEIVED
08/25/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2025
PUBO
PUBLISHED FOR OPPOSITION
02/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/21/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/20/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/20/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/20/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/17/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/17/2024
GNFR
FINAL REFUSAL E-MAILED
10/17/2024
CNFR
FINAL REFUSAL WRITTEN
10/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2024
ALIE
ASSIGNED TO LIE
09/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/23/2024
GNRT
NON-FINAL ACTION E-MAILED
03/23/2024
CNRT
NON-FINAL ACTION WRITTEN
03/23/2024
DOCK
ASSIGNED TO EXAMINER
03/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2023
NWAP
NEW APPLICATION ENTERED
07/21/2023
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOVX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.